Moderna stock: buy or sell
Jul 29th, 2021
Moderna stock brief
- After making new highs last Monday, Moderna closed on Wednesday at $349.32 exploding a 6.34%
- The stock is configuring an uptrend pattern since last March, when it bottomed at $117.34. This rally marked a 197.70% gain
Should I buy Moderna stock?
All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best
Is $MRNA stock a buy?
Currently, Moderna stock doesn't match any of these trading strategies, so our recommendation is not to buy now. This doesn't mean $MRNA will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems
Should I sell Moderna stock?
When you are a novel trader and you own a stock with some profit, it's really difficult to decide the good moment to sell and get your profits. Like when we have to buy shares, deciding when is appropiate to sell is not a haphazard decision, and we must use our own trading strategy. When selling, as well as buying, our strategies are very simple to follow and are only valid for selling shares in your porfolio, not for shorting $MRNA stock
A guiding principle is that you must never mantain an operation that leads to losses greater than those expected upon the buy. The timing to sell your stock must always be determined by the stop-loss (automatic or manual)
Is it time to sell Moderna stock?
In the current situation of Moderna there is not any eligible sell setup, so Moderna stock holders with operations in green can keep their positions
We don't have any rating posted in the previous month for Moderna
Moderna stock analysis
Moderna shares started an uptrend last March, and grew a gorgeous 197.70%. The chart shows higher peaks and higher lows, and along the way provided some buy points for those who wanted to invest. Latest pullback was in mid-June, when price bounced at $193.20. Like in all uptrends, price needs to rest and now price is consolidating the gains in a range between $362.00 and $193.20
$MRNA at new All-time Highs
Last Monday, Moderna reached all-time highs (ATH) again at $362.00. It's the fifth time in the last 10 sessions, marking an important rally
Supports and resistances
The current resistances are:
The current supports are:
Since the price surpassed the upper band last Friday, the price has been corrected downwards by 0.04%. The price is moving very close to the upper Bollinger band, indicating some level of overbought in recent sessions. This is not a bearish indicator, as price can move in these levels for many days and weeks
Relative strength index
Crossed up the overbought line Wednesday, with a value of 77.24. Contrary to what many investors may think, the fact that the value is in the overbought zone does not imply a sell signal, as shares can climb during several weeks being in the overvalued zone
Moderna stock price history
Moderna went public priced at an adjusted price1 of $22.00 on Dec 2018. Since then, MRNA stock has risen by 1,487.82%, with an average of 743.91% per year. If you had invested thousand dollars in Moderna stock at that time, it would worth $15,878.18 today.
1: Adjusted price after possible price splits or reverse-splits
Price target for Moderna stock
Nobody can predict how much a stock will be priced in the future. However, many stock price forecasts are posted every day by banks, financial institutions and independent analysts.
The following table shows the price predictions published by analysts for the last 30 days. If you are a small trader you don't have to buy or sell based on these price targets.
We don't have any target price posted in the previous 4 weeks for Moderna.
Earnings and financials
Investors call was hosted by Moderna ($MRNA) last May after releasing the financial report. Moderna topped Wall St estimates and posted of $2.84, that is a 18.83% surprise compared to the initial estimates of $2.39. Instead, reported revenues were $1.9 billion versus estimates of $2.0 billion.Same quarter one year ago, reported EPS was $-0.35, so recently posted EPS is an increase of 911.43%. Turnover exploded a 22,989.76% on an annualized basis in the , from $83.9M to $19.4B last quarter.
Moderna ($MRNA) will host the Q2 earnings call next Wednesday. Analysts estimate of $5.95, that is a 109.51% more than previous quarter.
Important:The viewpoints contained in this article are personal and not recommendations for you to buy or sell stocks. The author of this document does not know the specific conditions of the reader, his or her finances or what is in his or her best interest at any given time. All users should speak with their financial advisor before buying or selling any securities Comments are published for learning purposes only
|Wednesday, July 28th, 2021|
|Day range||$327.5 - $350.99|
|Average true range||$29.18|
|50d mov avg||$226.55|
|100d mov avg||$188.30|
|200d mov avg||$155.82|
|Earnings date||August 4th, 2021|